NCT00003664View on ClinicalTrials.gov

Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically

PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 1998

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

recombinant interferon alfa

DRUG

fluorouracil

DRUG

gemcitabine hydrochloride

Trial Locations (2)

47402

Bloomington Hospital, Bloomington

68124

Bergan Mercy Medical Center, Omaha

Sponsors
All Listed Sponsors
lead

Cancer Biotherapy Research Group

OTHER

NCT00003664 - Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically | Biotech Hunter | Biotech Hunter